Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-20.16	51.24	64.18
Graham Fair Price	9.01	3.59	3.29
PEG	0.65	1.18	-1.17
Price/Book	-24.71	0.78	1.04
Price/Cash Flow	86.28	35.66	-19.14
Prices/Earnings	-35.52	22.46	34.83
Price/Sales	-32.46	5.13	7.59
Price/FCF	86.28	35.66	-19.14
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	25.11	0.38	0.31
Operating Margin	-1.97	0.06	0.06
ROA	19.77	< 0.005	< 0.005
ROE	< 0.005	< 0.005	16.77
ROIC	< 0.005	< 0.005	15.55
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.21	-0.13	-62.55
Dividends QOQ	-0.02	0.04	92.38
EBIT QOQ	0.62	0.10	-83.59
EPS QOQ	-0.30	0.19	-35.94
FCF QOQ	-1.87	1.41	-24.55
Revenue QOQ	-0.33	0.12	-61.69
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	74.61	70.83	-5.06
Days Sales Outstanding (DSO)	160.35	151.62	-5.45
Inventory Turnover	1.21	1.27	5.33
Debt/Capitalization	0.10	0.08	-19.71
Quick Ratio	1.07	1.04	-3.15
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	8.03	8.36	4.06
Cash	3.92	3.15	-19.56
Capex	-0.19	0.08	-57.57
Free Cash Flow	-0.44	0.18	-59.22
Revenue	1.10	1.24	12.46
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.20	1.16	-3.92
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-35.06	-30.77	12.24
Naive Interpretation	Member

06 - Financial Health · Bad

Rating